Literature DB >> 22851165

Immunosuppressive prednisolone enhances early cholangiocarcinoma in Syrian hamsters with liver fluke infection and administration of N-nitrosodimethylamine.

Amornrat Juasook1, Thidarut Boonmars, Zhiliang Wu, Watcharin Loilome, Kulathida Veteewuthacharn, Nissana Namwat, Pakkayanee Sudsarn, Orasa Wonkchalee, Pranee Sriraj, Ratchadawan Aukkanimart.   

Abstract

Chronic infection with Opisthorchis viverrini for many years has been associated with the development of hepatobiliary diseases including cholangiocarcinoma. It is well known that inflammation is a key component of the tumor microenvironment, and that chronic inflammation plays an important role in tumorigenesis. Therefore, in this study cholangiocarcinogenesis was induced in Syrian hamsters in order to observe the cancer-related inflammation. The Syrian hamsters were divided into 5 groups: uninfected controls; normal Syrian hamsters infected with O. viverrini (OV); immunosuppressed Syrian hamsters infected with O. viverrini (OVis); normal Syrian hamsters infected with O. viverrini and administered N-nitrosodimethylamine (CCA); and immunosuppressed Syrian hamsters infected with O. viverrini and administered N-nitrosodimethylamine (CCAis). Syrian hamster livers were later observed for gross pathology and histopathological changes; COX2 was analyzed by immunohistochemical staining. We found a decreased number of inflammatory cells surrounding the hepatic bile duct in the OVis group, but not in the OV and CCAis groups. However, in the CCAis group (with suppressed immunity) early appearance and greater severity of cholangiocarcinoma were observed; gross pathological examination revealed many cancer nodularities on the liver surface, and histopathological studies showed the presence of cancer cells, findings which correlated with the predominant expression of COX2. The present study suggests that host immune responses are intended to ameliorate pathology, and they are also crucially associated with pathogenesis in O. viverrini infection; the unbalancing of host immunity may enhance cancer-related inflammation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22851165     DOI: 10.1007/s12253-012-9557-1

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  46 in total

Review 1.  Biliary cancer growth factor pathways, cyclo-oxygenase-2 and potential therapeutic strategies.

Authors:  A E Sirica; G H Lai; Z Zhang
Journal:  J Gastroenterol Hepatol       Date:  2001-04       Impact factor: 4.029

Review 2.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

3.  Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear.

Authors:  Dennis R Trune; J Beth Kempton; Neil D Gross
Journal:  Hear Res       Date:  2005-11-22       Impact factor: 3.208

4.  Discovery of a novel COX-2 inhibitor as an orally potent anti-pyretic and anti-inflammatory drug: design, synthesis, and structure-activity relationship.

Authors:  Shigeo Hayashi; Yoko Sumi; Naomi Ueno; Akio Murase; Junji Takada
Journal:  Biochem Pharmacol       Date:  2011-07-02       Impact factor: 5.858

Review 5.  Oxidants, antioxidants, and the degenerative diseases of aging.

Authors:  B N Ames; M K Shigenaga; T M Hagen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

6.  Localization of cyclooxygenase-2 in human sporadic colorectal adenomas.

Authors:  K S Chapple; E J Cartwright; G Hawcroft; A Tisbury; C Bonifer; N Scott; A C Windsor; P J Guillou; A F Markham; P L Coletta; M A Hull
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

7.  Indirect effect of a turmeric diet: enhanced bile duct proliferation in Syrian hamsters with a combination of partial obstruction by Opisthorchis viverrini infection and inflammation by N-nitrosodimethylamine administration.

Authors:  Sirintip Boonjaraspinyo; Thidarut Boonmars; Chantana Aromdee; Anucha Puapairoj; Zhiliang Wu
Journal:  Parasitol Res       Date:  2010-09-07       Impact factor: 2.289

Review 8.  Glucocorticosteroids for primary sclerosing cholangitis.

Authors:  Vanja Giljaca; Goran Poropat; Davor Stimac; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

9.  Apoptosis-related gene expressions in hamsters re-infected with Opisthorchis viverrini and re-treated with praziquantel.

Authors:  T Boonmars; T Srisawangwong; P Srirach; B Kaewsamut; S Pinlaor; P Sithithaworn
Journal:  Parasitol Res       Date:  2007-09-13       Impact factor: 2.289

Review 10.  Regulatory T cells and IL-10 in allergic inflammation.

Authors:  Catherine M Hawrylowicz
Journal:  J Exp Med       Date:  2005-12-05       Impact factor: 14.307

View more
  7 in total

1.  Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma.

Authors:  Pakkayanee Sudsarn; Thidarut Boonmars; Wipaporn Ruangjirachuporn; Nisana Namwat; Watcharin Loilome; Pranee Sriraj; Ratchadawan Aukkanimart; Wonkchalee Nadchanan; Songsri Jiraporn
Journal:  Pathol Oncol Res       Date:  2015-08-16       Impact factor: 3.201

2.  A combination of liver fluke infection and traditional northeastern Thai foods associated with cholangiocarcinoma development.

Authors:  Pranee Sriraj; Thidarut Boonmars; Ratchadawan Aukkanimart; Jiraporn Songsri; Panupan Sripan; Panaratana Ratanasuwan; Sirintip Boonjaraspinyo; Nadchanan Wongchalee; Porntip Laummaunwai
Journal:  Parasitol Res       Date:  2016-06-07       Impact factor: 2.289

3.  A combination of praziquantel and the traditional medicinal plant Thunbergia laurifolia on Opisthorchis viverrini infection and cholangiocarcinoma in a hamster model.

Authors:  Nadchanan Wonkchalee; Thidarut Boonmars; Porntip Laummaunwai; Chantana Aromdee; Chariya Hahnvajanawong; Zhiliang Wu; Pranee Sriraj; Ratchadawan Aukkanimart; Yaovaluk Chamgramol; Chawalit Pairojkul; Amornrat Juasook; Pakkayanee Sudsarn
Journal:  Parasitol Res       Date:  2013-09-21       Impact factor: 2.289

4.  Cytokine profiles in Opisthorchis viverrini stimulated peripheral blood mononuclear cells from cholangiocarcinoma patients.

Authors:  Arpa Surapaitoon; Sutas Suttiprapa; Narong Khuntikeo; Chawalit Pairojkul; Banchob Sripa
Journal:  Parasitol Int       Date:  2016-10-18       Impact factor: 2.230

5.  Tumor-related gene changes in immunosuppressive Syrian hamster cholangiocarcinoma.

Authors:  Amornrat Juasook; Ratchadawan Aukkanimart; Thidarut Boonmars; Pakkayanee Sudsarn; Nadchanan Wonkchalee; Porntip Laummaunwai; Pranee Sriraj
Journal:  Pathol Oncol Res       Date:  2013-05-06       Impact factor: 3.201

6.  Acetaminophen Overdose Enhances Early Cholangiocarcinoma in Opisthorchiasis Hamsters.

Authors:  Pranee Sriraj; Thidarut Boonmars; Ratchadawan Aukkanimart; Atchara Artchayasawat; Glenn N Borlace; Panaratana Ratanasuwan; Benjamabhorn Pumhirunroj
Journal:  Asian Pac J Cancer Prev       Date:  2021-12-01

7.  Evaluation of Hepatoprotective Effect of Curcumin on Liver Cirrhosis Using a Combination of Biochemical Analysis and Magnetic Resonance-Based Electrical Conductivity Imaging.

Authors:  Eun Jung Kyung; Hyun Bum Kim; Eun Sang Hwang; Seok Lee; Bup Kyung Choi; Jin Woong Kim; Hyung Joong Kim; Sang Moo Lim; Oh In Kwon; Eung Je Woo
Journal:  Mediators Inflamm       Date:  2018-05-17       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.